<DOC>
	<DOCNO>NCT01663987</DOCNO>
	<brief_summary>A randomized , placebo-controlled , double-blind , parallel group , multi center study assess safety efficacy tiotropium bromide ( 18 µg ) deliver via HandiHaler® Chronic Obstructive Pulmonary Disease ( COPD ) subject recover hospitalization acute exacerbation ( Hospital Discharge 1 )</brief_summary>
	<brief_title>Investigate Impact Early Treatment Initiation With Tiotropium Patients Recovering From Hospitalization Acute COPD Exacerbation 1</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : The follow inclusion criterion apply Visit 0 : 1 . All subject must sign informed consent consistent International Conference Harmonization Good Clinical Practice ( ICHGCP ) guideline prior participation trial conduct study procedure . 2 . Male female subject 40 year age old . 3 . Hospitalization primary diagnosis acute COPD exacerbation =14 day . Determination accuracy admission diagnosis discretion investigator . 4 . Patient report hospital length stay discharge date ( confirmed hospital discharge summary/hospital record ; however , medical record confirmation may occur follow randomization ) . The following inclusion criterion apply Visit 1 : 5 . Discharged hospital =10 day date randomization . 6 . All subject must diagnosis COPD ( P1201205 ) , document airway obstruction postbronchodilator FEV1/FVC &lt; 0.7 ( See Section 5.1.2 , Pulmonary Function Testing ) . The diagnosis COPD make Visit 1 PFT data available within past 12 month . 7 . Subjects must current exsmoker smoke history =10 packyears : Packyears = Number cigarettes/day x year smoke 20 cigarettes/ pack 8 . Subjects must able inhale medication competent manner HandiHaler® device ( Appendix 10.1 ) meter dose inhaler ( MDI ) . Exclusion criterion : The following exclusion criterion applies Visit 0 : 1 . No 30 day therapy longacting inhale anticholinergic precede 3 month prior discharge hospital , therapy long act anticholinergic post discharge ( use hospital discharge randomization ) restrict concomitant medication The following exclusion criterion apply Visit 1 : 2 . Presence significant disease ( opinion investigator ) may put subject risk participation study may influence subject 's ability participate study 2 year . 3 . A documented history myocardial infarction hospitalization precede randomization . Subjects stable history cardiac stent permit . 4 . Any unstable lifethreatening cardiac arrhythmia require intervention change drug therapy last year . 5 . Subjects asthma ( subject treat asthma last 2 year , history childhood asthma permit ) , cystic fibrosis , clinical diagnosis bronchiectasis , interstitial lung disease , pulmonary thromboembolic disease know active tuberculosis . 7 . Malignancy subject undergone resection , radiation , chemotherapy biological treatment within last two year currently active radiation therapy , chemotherapy biological treatment . Subjects treat basal cell carcinoma noninvasive squamous cell skin carcinoma allow . 8 . Hospitalization cardiac failure ( New York Heart Association ( NYHA ) class III IV ) hospitalization precede randomization . 9 . Known hypersensitivity anticholinergic drug , lactose , component HandiHaler® MDI inhalation solution delivery system . 10 . Known moderate severe renal impairment judge investigator . 11 . Known narrow angle glaucoma judge investigator . 12 . Significant symptomatic prostatic hyperplasia bladderneck obstruction . Subjects whose symptom control treatment may include . 13 . Pregnant nursing woman woman childbearing potential use medically approve mean contraception ( i.e. , oral contraceptive , intrauterine device , diaphragm sub dermal implant e.g. , Norplant ) least three month prior duration trial . 14 . Significant alcohol drug abuse within past 12 month . 15 . Previously randomize study currently participate another interventional study . 16 . Visual impairment judge investigator allow subject independently read complete questionnaire eDiary . 17 . Any significant new ECG finding Visit 1 judge investigator , include , limited sign acute ischemia , arrhythmia . 18 . Treatment restrict pulmonary medication . 19 . Residing assist living facility .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>